Leaderboards/Soft tissue tumors and treatment

Soft tissue tumors and treatment

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
David Papke
Brigham and Women's Hospital
2
Amir Momeni Boroujeni
Memorial Sloan Kettering Cancer Center
3
Lennart Well
Hamburg Institut (Germany)
4
Ryuji Iwamura
University of Occupational and Environmental Health Japan
5
Chloé Cammareri
Université de Bordeaux
6
Massimo Pisano
University of Salerno
7
Calixto‐Hope G. Lucas
Johns Hopkins University
8
Mehdi Debaibi
Tunis University
9
Hussain A Al Ghadeer
Maternity and Children's Hospital
10
Meng Zhang
Catholic Medical Center

Rising Stars Papers

1
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Nature Genetics|2024
55 cit.
2
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1
Neuro-Oncology|2024
26 cit.
3
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses
Neuro-Oncology|2024
23 cit.
4
Epithelioid Fibrous Histiocytoma Is on a Continuum With Superficial ALK-rearranged Myxoid Spindle Cell Neoplasm
The American Journal of Surgical Pathology|2024
18 cit.
5
Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas
Modern Pathology|2024
17 cit.
6
Pulp regeneration treatment using different bioactive materials in permanent teeth of pediatric subjects
Journal of Conservative Dentistry and Endodontics|2024
15 cit.
7
Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification
Gynecologic Oncology|2024
13 cit.
8
Myxoid Inflammatory Myofibroblastic Sarcoma
The American Journal of Surgical Pathology|2024
12 cit.
9
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI
Neuro-Oncology Advances|2024
11 cit.
10
MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive Subtypes
Modern Pathology|2025
10 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Chien-Liang Ho
Chi Mei Medical Center
2
Luxi Sun
Chinese Academy of Medical Sciences & Peking Union Medical College
3
Leslie R. Lamb
Harvard University
4
Sarah Chiang
Memorial Sloan Kettering Cancer Center
5
Erik C. Thorland
Mayo Clinic in Arizona
6
Melissa M. Blessing
University of Iowa Health Care
7
Zhiyv Niu
Mayo Clinic
8
Agata Polizzi
University of Catania
9
Mengyun Zhou
Shanghai University of Traditional Chinese Medicine
10
Yuqing Cheng
Changzhou No.2 People's Hospital

Emerging Leaders Papers

1
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
Modern Pathology|2023
49 cit.
2
Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas
Modern Pathology|2024
17 cit.
3
Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer
International Journal of Gynecological Cancer|2024
12 cit.
4
Comparison of the Diagnostic Accuracy of Mammogram-based Deep Learning and Traditional Breast Cancer Risk Models in Patients Who Underwent Supplemental Screening with MRI
Radiology|2023
11 cit.
5
DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas
Modern Pathology|2023
8 cit.
6
Differences in clinicopathology and prognosis between gastroesophageal junctional and gastric non-cardiac neuroendocrine carcinomas: a retrospective comparison study of consecutive 56 cases from a single institution in China.
PubMed|2022
6 cit.
7
Predicting ipsilateral recurrence in women treated for ductal carcinoma in situ using machine learning and multivariable logistic regression models
Clinical Imaging|2022
4 cit.
8
Clinicopathological features and prognosis of alpha‐fetoprotein‐producing colorectal adenocarcinoma
Histopathology|2024
4 cit.
9
Automation of hybridization and capture based next generation sequencing library preparation requires reduction of on-deck bead binding and heated wash temperatures
SLAS TECHNOLOGY|2022
3 cit.
10
Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series
Therapeutic Advances in Chronic Disease|2022
2 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Christopher D.�M. Fletcher
Brigham and Women's Hospital
2
Sharon W. Weiss
Tel Aviv University
3
David H. Gutmann
Washington University in St. Louis
4
Miikka Vikkula
Unknown
5
Silvia Stacchiotti
Fondazione IRCCS Istituto Nazionale dei Tumori
6
Jean‐Yves Blay
Université Claude Bernard Lyon 1
7
P. Wolkenstein
Université Paris-Est Créteil
8
Nancy Ratner
Cincinnati Children's Hospital Medical Center
9
Susan S. Devesa
National Institutes of Health
10
Cristina R. Antonescu
Memorial Sloan Kettering Cancer Center

Current Senior Leaders Papers

1
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
2
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Cancer|1998
2.1k cit.
3
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2018
1.6k cit.
4
Malignant fibrous histiocytoma.An Analysis of 200 Cases
Cancer|1978
1.5k cit.
5
Epithelioid hemangioendothelioma a vascular tumor often mistaken for a carcinoma
Cancer|1982
1.4k cit.
6
The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
JAMA|1997
1.3k cit.
7
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Annals of Oncology|2021
989 cit.
8
Inflammatory Myofibroblastic Tumor
The American Journal of Surgical Pathology|2007
972 cit.
9
International trends and patterns of prostate cancer incidence and mortality
International Journal of Cancer|2000
838 cit.
10
Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation
Clinical Cancer Research|2005
831 cit.

Reagents for Soft tissue tumors and treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

🌟 All-Time

Most validated

Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

Cited in 5 papers
#A4502
View Evidence →